These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20735223)

  • 1. Intracellular drug delivery by genetically engineered high-density lipoprotein nanoparticles.
    Murakami T; Wijagkanalan W; Hashida M; Tsuchida K
    Nanomedicine (Lond); 2010 Aug; 5(6):867-79. PubMed ID: 20735223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid nanodisc engineering for drug delivery systems.
    Murakami T
    Biotechnol J; 2012 Jun; 7(6):762-7. PubMed ID: 22581727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.
    Pan L; Liu J; He Q; Wang L; Shi J
    Biomaterials; 2013 Apr; 34(11):2719-30. PubMed ID: 23337327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
    Chen YP; Chen CT; Hung Y; Chou CM; Liu TP; Liang MR; Chen CT; Mou CY
    J Am Chem Soc; 2013 Jan; 135(4):1516-23. PubMed ID: 23289802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.
    Damiano MG; Mutharasan RK; Tripathy S; McMahon KM; Thaxton CS
    Adv Drug Deliv Rev; 2013 May; 65(5):649-62. PubMed ID: 22921597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.
    Zhao JF; Chen JY; Mi L; Wang PN; Peng Q
    Ultrastruct Pathol; 2011 May; 35(3):119-23. PubMed ID: 21405950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly of Coenzyme Q10 nanostructure resembling nascent discoidal high density lipoprotein particle.
    Shin JY; Shin JI; Kim JS; Yang YS; Hwang Y; Yang JS; Shin D; Seo JH; Jin YS; Park YC; Hwang JS; Kweon DH
    Biochem Biophys Res Commun; 2009 Oct; 388(2):217-21. PubMed ID: 19646960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.
    Lin Q; Chen J; Jin H; Ng KK; Yang M; Cao W; Ding L; Zhang Z; Zheng G
    Nanomedicine (Lond); 2012 Dec; 7(12):1813-25. PubMed ID: 22830501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
    Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
    Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
    Harada H; Hiraoka M; Kizaka-Kondoh S
    Cancer Res; 2002 Apr; 62(7):2013-8. PubMed ID: 11929818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells.
    Chen G; Da L; Wang H; Xu Y; Chen G; Sun C; Wang L; Zhao J; Zhang F; Feng J; Wang Y; Tiollais P; Li T; Zhao M
    Gastroenterology; 2011 Jan; 140(1):332-43. PubMed ID: 20816839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
    Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
    J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
    Liu L; Guo K; Lu J; Venkatraman SS; Luo D; Ng KC; Ling EA; Moochhala S; Yang YY
    Biomaterials; 2008 Apr; 29(10):1509-17. PubMed ID: 18155137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery.
    Di W; Ren X; Zhao H; Shirahata N; Sakka Y; Qin W
    Biomaterials; 2011 Oct; 32(29):7226-33. PubMed ID: 21745687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.